selected publications
- Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. Journal of the American College of Cardiology. 2024 Academic Article GET IT
- Tissue-Based Predictors of Impaired Right Ventricular Strain in Coronary Artery Disease: A Multicenter Stress Perfusion Study. Circulation. Cardiovascular imaging. 2024 Academic Article GET IT
- Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension. European journal of heart failure. 2024 Academic Article GET IT
- Impact of Age of Heart Transplant Program on Patient Survival and Post-Transplant Outcomes. Clinical transplantation. 2024 Academic Article GET IT
- Pulmonary hypertension across the spectrum of left heart and lung disease. European journal of heart failure. 2024 Academic Article GET IT
- Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019). Pulmonary circulation. 2024 Academic Article GET IT
- Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions. Circulation. Heart failure. 2024 Academic Article GET IT
- Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension. Chest. 2024 Academic Article GET IT
-
Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
Journal of the American College of Cardiology.
2023
Academic Article
GET IT
Times cited: 1 - Sex Disparities in the Management, Outcomes, and Transfer of Patients Hospitalized for Cardiogenic Shock. Journal of the Society for Cardiovascular Angiography & Interventions. 2023 Academic Article GET IT
- Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. American journal of physiology. Lung cellular and molecular physiology. 2023 Academic Article GET IT
- Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension. Circulation. Heart failure. 2023 Academic Article GET IT
- Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary circulation. 2023 Academic Article GET IT
-
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
European heart journal.
2023
Academic Article
GET IT
Times cited: 22 - Hidden Bias: The Intersection of Ageism and Gender in Adult Cardiology. JACC. Heart failure. 2023 Editorial Article GET IT
- Impact of acute TTE-evidenced cardiac dysfunction on in-hospital and outpatient mortality: A multicenter NYC COVID-19 registry study. PloS one. 2023 Academic Article GET IT
- Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2023 Review GET IT
- Iron Deficiency in Pulmonary Vascular Disease: Pathophysiological and Clinical Implications. European heart journal. 2023 Academic Article GET IT
- Pulmonary artery compliance in different forms of pulmonary hypertension. Heart (British Cardiac Society). 2023 Academic Article GET IT
- Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary circulation. 2023 Academic Article GET IT
- More COACHing Needed to Optimize Care after Heart Failure Hospitalization. The New England journal of medicine. 2023 Editorial Article GET IT
-
Direct comparison of echocardiography speckle tracking and cardiac magnetic resonance feature tracking for quantification of right ventricular strain: a prospective intermodality study in functional mitral regurgitation.
Echo research and practice.
2022
Academic Article
GET IT
Times cited: 3 - Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR). The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022 Academic Article GET IT
- Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. Journal of the American College of Cardiology. 2022 Academic Article GET IT
- Post-operative atrial fibrillation and risk of heart failure hospitalization. European heart journal. 2022 Academic Article GET IT
- Detecting early physiologic changes through cardiac implantable electronic device data among patients with COVID-19. Cardiovascular digital health journal. 2022 Academic Article GET IT
-
Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation.
Heart rhythm O2.
2022
Academic Article
GET IT
Times cited: 7 - ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022 Editorial Article GET IT
- Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease. Clinical cardiology. 2022 Academic Article GET IT
-
Impact of Socioeconomic Status on Mechanical Circulatory Device Utilization and Outcomes in Cardiogenic Shock.
Journal of the Society for Cardiovascular Angiography & Interventions.
2022
Academic Article
GET IT
Times cited: 3 -
Acute COVID-19-Associated Decrements in Left and Right Ventricular Function Predict All-Cause Mortality.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
2021
Academic Article
GET IT
Times cited: 4 -
Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world.
European journal of heart failure.
2021
Academic Article
GET IT
Times cited: 1 - Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience. European heart journal. Cardiovascular Imaging. 2021 Academic Article GET IT
- Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?. Circulation. Heart failure. 2021 Academic Article GET IT
- Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulmonary circulation. 2021 Academic Article GET IT
- NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021 Information Resource GET IT
-
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
American journal of respiratory and critical care medicine.
2021
Article
GET IT
Times cited: 12 - Novel Echocardiographic Algorithm for Right Ventricular Mass Quantification: Cardiovascular Magnetic Resonance and Clinical Prognosis Validation. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2021 Academic Article GET IT
-
Pulmonary Hypertension in Pregnancy.
Clinics in chest medicine.
2021
Information Resource
GET IT
Times cited: 1 -
Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers.
Journal of the American Heart Association.
2020
Academic Article
GET IT
Times cited: 12 -
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.
Journal of the American College of Cardiology.
2020
Academic Article
GET IT
Times cited: 81 -
Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR).
Annals of the American Thoracic Society.
2020
Academic Article
GET IT
Times cited: 19 -
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19.
Journal of cardiac failure.
2020
Academic Article
GET IT
Times cited: 10 -
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
2020
GET IT
Times cited: 75 -
United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
Clinical transplantation.
2020
Academic Article
GET IT
Times cited: 17 -
Obesity and COVID-19 in New York City: A Retrospective Cohort Study.
Annals of internal medicine.
2020
Letter
GET IT
Times cited: 68 - Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'". Pulmonary circulation. 2020 Academic Article GET IT
- Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?. Pulmonary circulation. 2020 Academic Article GET IT
-
Clinical Characteristics of Covid-19 in New York City.
The New England journal of medicine.
2020
Letter
GET IT
Times cited: 1646 - Association of Hospital Volume with 30-Day Readmission Following Left Ventricular Assist Device Implantation. Journal of cardiac failure. 2020 Letter GET IT
-
Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization.
The American journal of cardiology.
2020
Academic Article
GET IT
Times cited: 5 -
Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation - initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
2019
Academic Article
GET IT
Times cited: 12 -
Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
2019
Academic Article
GET IT
Times cited: 13 - Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group II pulmonary hypertension. Journal of echocardiography. 2018 Academic Article GET IT
-
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
International journal of cardiology.
2018
Academic Article
GET IT
Times cited: 28 -
Systemic blood pressure trends and antihypertensive utilization following continuous-flow left ventricular assist device implantation: an analysis of the interagency registry for mechanically assisted circulatory support.
Journal of thoracic disease.
2018
Academic Article
GET IT
Times cited: 8 -
Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services.
The American journal of cardiology.
2018
Academic Article
GET IT
Times cited: 18 -
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.
Circulation research.
2017
Academic Article
GET IT
Times cited: 111 -
Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?.
Journal of the American Geriatrics Society.
2017
Academic Article
GET IT
Times cited: 56 -
Characteristics of hospitalizations for cardiogenic shock after acute myocardial infarction in the United States.
International journal of cardiology.
2017
Academic Article
GET IT
Times cited: 6 -
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Autoimmunity reviews.
2017
Information Resource
GET IT
Times cited: 26 -
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.
Journal of the American Heart Association.
2017
Academic Article
GET IT
Times cited: 36 -
Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
Rheumatology (Oxford, England).
2016
Academic Article
GET IT
Times cited: 3 -
Patterns of scheduled follow-up appointments following hospitalization for heart failure: insights from an urban medical center in the United States.
Clinical interventions in aging.
2016
Academic Article
GET IT
Times cited: 8 -
Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.
Cardiology clinics.
2016
Information Resource
GET IT
Times cited: 10 -
Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.
The American journal of medicine.
2016
Academic Article
GET IT
Times cited: 51 -
Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance.
PloS one.
2016
Academic Article
GET IT
Times cited: 8 -
Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
Annals of the American Thoracic Society.
2016
Academic Article
GET IT
Times cited: 57 -
Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
The Journal of thoracic and cardiovascular surgery.
2015
Academic Article
GET IT
Times cited: 10 -
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.
Annals of the American Thoracic Society.
2015
Academic Article
GET IT
Times cited: 32 -
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model.
The American journal of cardiology.
2015
Academic Article
GET IT
Times cited: 30 -
Outcomes of patients implanted with a left ventricular assist device at nontransplant mechanical circulatory support centers.
The American journal of cardiology.
2015
Academic Article
GET IT
Times cited: 12 -
Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
The international journal of cardiovascular imaging.
2014
Academic Article
GET IT
Times cited: 19 -
Functional mitral regurgitation: therapeutic strategies for a ventricular disease.
Journal of cardiac failure.
2014
Information Resource
GET IT
Times cited: 18 -
Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.
Arthritis care & research.
2013
Academic Article
GET IT
Times cited: 5 -
Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function.
Journal of cardiovascular computed tomography.
2013
Academic Article
GET IT
Times cited: 12 -
Preoperative assessment of high-risk candidates to predict survival after heart transplantation.
Circulation. Heart failure.
2013
Academic Article
GET IT
Times cited: 31 - Pulmonary vascular disease and the right ventricle. Introduction. Progress in cardiovascular diseases. 2012 Editorial Article GET IT
-
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.
European journal of heart failure.
2012
Academic Article
GET IT
Times cited: 24 -
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT.
Circulation.
2011
Academic Article
GET IT
Times cited: 109 -
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT.
Contemporary clinical trials.
2010
Academic Article
GET IT
Times cited: 9 -
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
American journal of respiratory and critical care medicine.
2009
Academic Article
GET IT
Times cited: 202 -
Physiologic determinants of mitral inflow pattern using a computer simulation: insights into Doppler echocardiography in diverse phenotypes.
Echocardiography (Mount Kisco, N.Y.).
2009
Academic Article
GET IT
Times cited: 1 -
Serotonin transporter polymorphisms in patients with portopulmonary hypertension.
Chest.
2009
Academic Article
GET IT
Times cited: 33 - Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest. 2008 Academic Article GET IT
-
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
2008
Academic Article
GET IT
Times cited: 32 -
Clinical risk factors for portopulmonary hypertension.
Hepatology (Baltimore, Md.).
2008
Academic Article
GET IT
Times cited: 232 -
Bloodstream infections in patients given treatment with intravenous prostanoids.
Infection control and hospital epidemiology.
2008
Academic Article
GET IT
Times cited: 71 -
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
Annals of the rheumatic diseases.
2007
Academic Article
GET IT
Times cited: 89 -
Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
Transplantation.
2007
Academic Article
GET IT
Times cited: 68 -
Plasma serotonin levels are normal in pulmonary arterial hypertension.
Pulmonary pharmacology & therapeutics.
2007
Academic Article
GET IT
Times cited: 26 -
Estimation of the optimal VV delay by an IEGM-based method in cardiac resynchronization therapy.
Pacing and clinical electrophysiology : PACE.
2007
Academic Article
GET IT
Times cited: 26 -
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.
Pulmonary pharmacology & therapeutics.
2006
Academic Article
GET IT
Times cited: 58 -
Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.
Expert review of cardiovascular therapy.
2005
Information Resource
GET IT
Times cited: 19 -
von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.
Chest.
2005
Academic Article
GET IT
Times cited: 61 -
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
Vascular pharmacology.
2005
Academic Article
GET IT
Times cited: 125 -
New predictors of outcome in idiopathic pulmonary arterial hypertension.
The American journal of cardiology.
2005
Academic Article
GET IT
Times cited: 183 -
Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.
Expert opinion on investigational drugs.
2004
Academic Article
GET IT
Times cited: 14 -
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
The European respiratory journal.
2004
Academic Article
GET IT
Times cited: 517 -
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.
The European respiratory journal.
2004
Academic Article
GET IT
Times cited: 85 -
Sitaxsentan therapy for pulmonary arterial hypertension.
American journal of respiratory and critical care medicine.
2003
Academic Article
GET IT
Times cited: 634 -
Sitaxsentan in pulmonary arterial hypertension.
Chest.
2003
Article
GET IT
Times cited: 2 -
Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.
The Journal of rheumatology.
2002
Academic Article
GET IT
Times cited: 76 -
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.
Chest.
2002
Academic Article
GET IT
Times cited: 217 -
Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
Journal of cardiac failure.
2000
Academic Article
GET IT
Times cited: 144 -
Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure.
Drugs.
2000
Information Resource
GET IT
Times cited: 20 -
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.
Chest.
2000
Article
GET IT
Times cited: 22 -
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Annals of internal medicine.
2000
Academic Article
GET IT
Times cited: 961 -
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33.
American journal of respiratory and critical care medicine.
2000
Academic Article
GET IT
Times cited: 75 -
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension.
Chest.
1999
Article
GET IT
Times cited: 30 -
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
Circulation.
1995
Academic Article
GET IT
Times cited: 353 -
Lymphocyte G proteins reflect response to treatment in congestive heart failure.
American heart journal.
1995
Academic Article
GET IT
Times cited: 4 -
Effect of innervation on heart rate response to mental stress.
Archives of general psychiatry.
1993
Academic Article
GET IT
Times cited: 14 -
Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons.
Transplantation.
1991
Academic Article
GET IT
Times cited: 8 -
The influence of detergents on the availability of pertussis toxin substrates.
Archives of biochemistry and biophysics.
1991
Academic Article
GET IT
Times cited: 6 -
Mechanisms of abnormal transmembrane signaling of the beta-adrenergic receptor in congestive heart failure.
Circulation.
1990
Information Resource
GET IT
Times cited: 22 -
Developmental changes in the electrophysiological properties and the beta-adrenergic receptor-effector complex in atrial fibers of the canine coronary sinus.
Circulation research.
1989
Academic Article
GET IT
Times cited: 6 -
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Circulation.
1988
Academic Article
GET IT
Times cited: 85 -
G protein-adrenergic interactions in the heart.
Molecular and cellular biochemistry.
1988
Academic Article
GET IT
Times cited: 4